APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 185 filers reported holding APELLIS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.84 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $112,905,787 | -8.9% | 1,239,361 | -34.1% | 0.34% | -12.5% |
| Q1 2023 | $123,986,595 | +4915.6% | 1,879,724 | +2406.3% | 0.38% | +3390.9% |
| Q3 2021 | $2,472,000 | -77.0% | 75,000 | -70.0% | 0.01% | -78.0% |
| Q1 2021 | $10,728,000 | +701.8% | 250,000 | +968.4% | 0.05% | +614.3% |
| Q4 2020 | $1,338,000 | -90.1% | 23,400 | -94.8% | 0.01% | -89.9% |
| Q3 2020 | $13,484,000 | +98.4% | 446,936 | +114.8% | 0.07% | +56.8% |
| Q2 2020 | $6,797,000 | -20.8% | 208,103 | -35.0% | 0.04% | -37.1% |
| Q1 2020 | $8,581,000 | -15.6% | 320,301 | -20.1% | 0.07% | +32.1% |
| Q2 2019 | $10,164,000 | +56.2% | 401,104 | +20.2% | 0.05% | +76.7% |
| Q1 2019 | $6,506,000 | +344.4% | 333,629 | +200.5% | 0.03% | +328.6% |
| Q4 2018 | $1,464,000 | – | 111,016 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 2,503,059 | $170,959,000 | 29.50% |
| ACUTA CAPITAL PARTNERS, LLC | 554,000 | $37,838,000 | 16.29% |
| Avoro Capital Advisors LLC | 10,125,000 | $691,538,000 | 12.78% |
| Sio Capital Management, LLC | 507,700 | $34,676,000 | 11.02% |
| Logos Global Management LP | 1,300,000 | $88,790,000 | 10.92% |
| EcoR1 Capital, LLC | 5,183,431 | $354,028,000 | 10.45% |
| Cormorant Asset Management, LP | 1,478,000 | $100,947,000 | 7.06% |
| Finepoint Capital LP | 266,090 | $18,174,000 | 5.98% |
| Ghost Tree Capital, LLC | 275,000 | $18,783,000 | 5.27% |
| Boxer Capital, LLC | 1,303,700 | $89,043,000 | 5.01% |